786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits

BACKGROUND: Nirmatrelvir coadministered with ritonavir (nirmatrelvir/r) is a COVID-19 treatment. This study evaluated nirmatrelvir/r in nonhospitalized, symptomatic adults with COVID-19 at high risk of progressing to severe disease. We report secondary efficacy endpoints associated with COVID-19─rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Simón Campos, Jesus Abraham, Pypstra, Rienk, Rusnak, James M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751968/
http://dx.doi.org/10.1093/ofid/ofac492.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751968/
http://dx.doi.org/10.1093/ofid/ofac492.047

Ejemplares similares